Related Experiment Videos
Accuracy of Pap tests reported as CIN I
1Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada. maire.duggan@crha-health.ab.ca
Diagnostic Cytopathology
|July 29, 1999
Summary
Papanicolaou (Pap) tests diagnosed as cervical intraepithelial neoplasia grade 1 (CIN I) have a 19.4% misclassification rate due to laboratory errors. Improving accuracy requires reducing screening and interpretative errors in Pap test analysis.
Area of Science:
- Gynecologic pathology
- Cervical cancer screening
- Cytopathology
Background:
- Papanicolaou (Pap) tests are crucial for cervical cancer screening.
- Cervical intraepithelial neoplasia grade 1 (CIN I) diagnoses are susceptible to laboratory misclassification.
- Screening and interpretative errors can impact Pap test accuracy.
Purpose of the Study:
- To determine the misclassification rate of Pap tests reported as CIN I.
- To analyze the causes of undercalled and overcalled Pap tests.
- To identify strategies for improving Pap test accuracy.
Main Methods:
- A panel of four pathologists conducted a peer-group consensus review of 449 Pap tests originally reported as CIN I.
- Tests were independently reviewed twice, with disagreements resolved by consensus.
- Misclassifications were categorized as screening or interpretative errors.
Main Results:
- The final classification revealed 19.4% misclassifications of Pap tests initially reported as CIN I.
- Of the misclassified tests, 6.9% were undercalled and 12.5% were overcalled.
- Screening errors accounted for 35.5% of undercalled tests; interpretative errors caused all overcalls and the remaining undercalls.
Conclusions:
- Pap tests reported as CIN I are subject to significant laboratory misclassification.
- Reducing screening and interpretative errors is essential for enhancing the accuracy of Pap test diagnoses.
- Improved laboratory practices can lead to more reliable cervical cancer screening results.